MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

23 Oct 2021 Evaluate
The topline advanced to Rs. 1166.89 millions, up 99.64% for the September 2021 quarter as against Rs. 584.51 millions during the year-ago period.The Total revenue for the quarter ended September 2021 of  Rs. 307.18  millions  grew by 951.27% from Rs. 29.22 millions.The company reported a good operating profit of 368.33 millions compared to 76.80 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202109 202009 % Var
Sales 1166.89 584.51 99.64 1166.89 584.51 99.64 1166.89 584.51 99.64
Other Income 25.96 17.35 49.63 25.96 17.35 49.63 25.96 17.35 49.63
PBIDT 368.33 76.80 379.60 368.33 76.80 379.60 368.33 76.80 379.60
Interest 12.24 9.87 24.01 12.24 9.87 24.01 12.24 9.87 24.01
PBDT 356.09 66.93 432.03 356.09 66.93 432.03 356.09 66.93 432.03
Depreciation 20.57 16.83 22.22 20.57 16.83 22.22 20.57 16.83 22.22
PBT 335.52 50.10 569.70 335.52 50.10 569.70 335.52 50.10 569.70
TAX 28.34 20.88 35.73 28.34 20.88 35.73 28.34 20.88 35.73
Deferred Tax -27.07 -4.83 460.46 -27.07 -4.83 460.46 -27.07 -4.83 460.46
PAT 307.18 29.22 951.27 307.18 29.22 951.27 307.18 29.22 951.27
Equity 221.65 80.35 175.86 221.65 80.35 175.86 221.65 80.35 175.86
PBIDTM(%) 31.57 13.14 140.24 31.57 13.14 140.24 31.57 13.14 140.24
Peers
Company Name CMP
Godrej Industries 1019.85
SRF 2422.20
BASF India 3310.55
Pidilite Inds. 1482.05
Tata Chemicals 637.20
View more..